Evidence map›Paper›PMID 35507753›Full record

ArticleBlood advances2022

Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura.

Jin-Sup Shin, Maryam Owais Subhan, Geraldine Cambridge, Yanping Guo, Rens de Groot, Marie Scully, Mari Thomas

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Challenges and opportunities in the long-term management of immune-mediated TTP.Hematology. American Society of Hematology. Education Program · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Jin-Sup ShinDepartment of Haematology, University College London Hospital, London, United Kingdom.
Maryam Owais SubhanInstitute of Cardiovascular Science.
Geraldine CambridgeCentre for Rheumatology Research, and.ORCID 0000-0002-6022-6322
Yanping GuoCancer Research UK Flow Cytometry Translational Technology Platform, Cancer Institute, University College London, London, United Kingdom; and.
Rens de GrootInstitute of Cardiovascular Science.ORCID 0000-0002-1044-9499
Marie ScullyDepartment of Haematology, University College London Hospital, London, United Kingdom.
Mari ThomasDepartment of Haematology, University College London Hospital, London, United Kingdom.ORCID 0000-0001-9288-7259
University College Hospital · GBCardiovascular Institute Hospital · JPCancer Research UK · GBCenter for Rheumatology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T follicular helper (Tfh) cells regulate development of antigen-specific B-cell immunity. We prospectively investigated B-cell and circulating Tfh (cTfh) cell subsets in 45 patients with immune thrombotic thrombocytopenic purpura (iTTP) at presentation and longitudinally after rituximab (RTX). B-cell phenotype was altered at acute iTTP presentation with decreased transitional cells and post-germinal center (post-GC) memory B cells and increased plasmablasts compared with healthy controls. A higher percentage of plasmablasts was associated with higher anti-ADAMTS13 IgG and lower ADAMTS13 antigen levels. In asymptomatic patients with ADAMTS13 relapse, there were increased naïve B cells and a global decrease in memory subsets, with a trend to increased plasmablasts. Total circulating Tfh (CD4+CXCR5+) and PD1+ Tfh cells were decreased at iTTP presentation. CD80 expression was decreased on IgD+ memory cells and double-negative memory cells in acute iTTP. At repopulation after B-cell depletion in de novo iTTP, post-GC and double-negative memory B cells were reduced compared with pre-RTX. RTX did not cause alteration in cTfh cell frequency. The subsequent kinetics of naïve, transitional, memory B cells and plasmablasts did not differ significantly between patients who went on to relapse vs those who remained in remission. In summary, acute iTTP is characterized by dysregulation of B- and cTfh cell homeostasis with depletion of post-GC memory cells and cTfh cells and increased plasmablasts. Changes in CD80 expression on B cells further suggest altered interactions with T cells.

Indexed as

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic ThrombocytopenicB-LymphocytesHumansReceptors, CXCR5RecurrenceRituximabT Follicular Helper CellsT-Lymphocytes, Helper-InducerReceptors, CXCR5Rituximab

Identifiers

PMID35507753
PMCPMC9631570
OpenAlexW4228996536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.